Omnicare - Chapter 11 Plan Terms

Omnicare's amended combined plan of reorganization and liquidation centers on the previously approved $250.0 million cash sale of substantially all operating assets to GenieRx Holdings, with certain debtors emerging as reorganized going-concern entities and the rest winding down under a plan administrator, Omnicare itself surviving to administer the wind-down assets. Rule 9019 settlements among the debtors, the DOJ, CVS Health and the creditors' committee allow the DOJ's $952.7 million claim from the August 2025 False Claims Act judgment in full but defer all recovery until Class 3 general unsecured claims are paid, with CVS's prepetition claims — including a $54.5 million proof of claim — subordinated behind both. JMB Capital Partners' $110.0 million DIP facility is repaid in full in cash on the effective date.

Plan Terms

Overview

Sale Transaction

DIP Financing

DOJ and CVS Settlements

Classification and Treatment of Claims and Interests

Unclassified Claims

Wind-Down Assets and Plan Administrator

Corporate Existence and Case Closure

Distributions

Claims Resolution and the Creditor Representative

Insurance and Insured Claims

Executory Contracts and Unexpired Leases

Releases, Exculpation and Injunction

Conditions Precedent to the Effective Date

Modification, Revocation, or Withdrawal

Retention of Jurisdiction

Tax Matters

Miscellaneous